Clinical Trial Update: Post Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's Disease

View source ↗

Summary

Post-marketing surveillance study for Mirapex (pramipexole) tablets in patients with Parkinson's disease has been completed, focusing on safety monitoring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mirapex (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED